Objective
 The complications for the use of both concentrations U100 insulin (100 units [U]/ml) and U40 insulin (40 units [U]/ml) were not studied in Egypt. The objective of the study was a cost minimization analysis of the two available concentrations for U100 insulin and U40 insulin from the healthcare system's perspective.
Methodology
 A decision analysis model of patients with diabetes was constructed.  Prevalence rates of diabetes in Egypt and complication rates of both the use of U100 insulin and U40 insulin were obtained from international published sources.  Direct medical costs were derived from the Ministry of Health tender list.  All costs were reported in Egyptian pounds of the financial year 2014.  Deterministic sensitivity analysis was conducted.  According to data derived from the National Institute for Diabetes and Endocrinology, hospitalization rate accompanying Insulin 40 units administration was high (averaging 40% of the patients for an average of 7 days/year). In contrast, Insulin 100 units doesn't possess such high rate. Its rate was small (3%).  Costs of hospitalization are variable from one site to another. It averages LE 500, ranging from a low of LE 300 (cases without complications) to LE 1,000 (cases in Intensive Care Unit or Insulin Pump usage).
Results
 Total expected costs for U100 insulin and U40 insulin were LE 262, 218, 165 and LE 345, 582, 844 respectively.  In the base case, the use of U100 insulin displayed a cost advantage over U40 insulin for the treatment of diabetic patients with a minimal percent of complications.  The model resulted in total savings of LE 83,364,678 in favor of Insulin 100 units.
 Sensitivity analyses determined that the cost of U100 insulin and U40 insulin had the potential to impact the base case model.
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Conclusion
 This cost-minimization study illustrates that Conversion to U100 insulin would result in lower overall treatment costs in patients with diabetes from the healthcare system's perspective.
 An intensive information campaign providing detailed advice for patients, physicians and pharmacists is essential for the prevention of medication errors and reduction of overall costs. 
